553-08-2,MFCD00133855
Catalog No.:AA00DB6K

553-08-2 | Thonzonium bromide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
10mg
≥98%
in stock  
$98.00   $68.00
- +
25mg
≥98%
in stock  
$218.00   $152.00
- +
50mg
in stock  
$379.00   $265.00
- +
100mg
≥98%
in stock  
$573.00   $401.00
- +
1g
in stock  
$2,008.00   $1,405.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00DB6K
Chemical Name:
Thonzonium bromide
CAS Number:
553-08-2
Molecular Formula:
C32H55BrN4O
Molecular Weight:
591.7093
MDL Number:
MFCD00133855
SMILES:
CCCCCCCCCCCCCCCC[N+](CCN(c1ncccn1)Cc1ccc(cc1)OC)(C)C.[Br-]
Properties
Properties
 
Form:
Solid  
MP:
95-98°C  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
515  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
38  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
22  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Literature

Title: Why are most phospholipidosis inducers also hERG blockers?

Journal: Archives of toxicology 20171201

Title: Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo.

Journal: Biochemical pharmacology 20160315

Title: Identification of clinically used drugs that activate pregnane X receptors.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20110101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Assay principle for modulators of protein-protein interactions and its application to non-ATP-competitive ligands targeting protein kinase A.

Journal: Analytical chemistry 20061215

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Zhu X, et al. Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo. Biochem Pharmacol. 2016;104:118-130.

Title: Chan CY, et al. Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p). J Biol Chem. 2012;287(13):10236-10250.

Title: Sims KR, et al. Enhanced design and formulation of nanoparticles for anti-biofilm drug delivery. Nanoscale. 2018;11(1):219-236.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 553-08-2
Tags:553-08-2 Molecular Formula|553-08-2 MDL|553-08-2 SMILES|553-08-2 Thonzonium bromide
Catalog No.: AA00DB6K
553-08-2,MFCD00133855
553-08-2 | Thonzonium bromide
Pack Size: 10mg
Purity: ≥98%
in stock
$98.00 $68.00
Pack Size: 25mg
Purity: ≥98%
in stock
$218.00 $152.00
Pack Size: 50mg
Purity:
in stock
$379.00 $265.00
Pack Size: 100mg
Purity: ≥98%
in stock
$573.00 $401.00
Pack Size: 1g
Purity:
in stock
$2,008.00 $1,405.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00DB6K
Chemical Name: Thonzonium bromide
CAS Number: 553-08-2
Molecular Formula: C32H55BrN4O
Molecular Weight: 591.7093
MDL Number: MFCD00133855
SMILES: CCCCCCCCCCCCCCCC[N+](CCN(c1ncccn1)Cc1ccc(cc1)OC)(C)C.[Br-]
Properties
Form: Solid  
MP: 95-98°C  
Storage: Inert atmosphere;Room Temperature;  
Complexity: 515  
Covalently-Bonded Unit Count: 2  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 38  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 22  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Literature fold

Title: Why are most phospholipidosis inducers also hERG blockers?

Journal: Archives of toxicology20171201

Title: Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo.

Journal: Biochemical pharmacology20160315

Title: Identification of clinically used drugs that activate pregnane X receptors.

Journal: Drug metabolism and disposition: the biological fate of chemicals20110101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Assay principle for modulators of protein-protein interactions and its application to non-ATP-competitive ligands targeting protein kinase A.

Journal: Analytical chemistry20061215

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Zhu X, et al. Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo. Biochem Pharmacol. 2016;104:118-130.

Title: Chan CY, et al. Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p). J Biol Chem. 2012;287(13):10236-10250.

Title: Sims KR, et al. Enhanced design and formulation of nanoparticles for anti-biofilm drug delivery. Nanoscale. 2018;11(1):219-236.

Building Blocks More >
55706-61-1
55706-61-1
quinoline-8-carboxamide
AA00DBBP | MFCD00508832
54024-21-4
54024-21-4
13b-Ethyl-11-methylenegon-4-en-17-one
AA00DBH4 | MFCD08458336
4553-27-9
4553-27-9
3-(4-Benzyl-piperazinyl)propanamine
AA00DBNV | MFCD03701704
53065-23-9
53065-23-9
2(3H)-Benzothiazolone,4-methoxy-,hydrazone(9CI)
AA00DBVA | MFCD04448795
463335-96-8
463335-96-8
2-Cyano-5-fluorophenylboronic acid pinacol ester
AA00DC24 | MFCD09878540
53109-32-3
53109-32-3
CYCLO(-HIS-PRO)
AA00DC7N | MFCD00133207
5438-24-4
5438-24-4
5,6-Dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione
AA00DCIM | MFCD00177933
51355-94-3
51355-94-3
6-Bromopyridazin-3(2h)-one
AA00DCKT | MFCD11223475
56227-56-6
56227-56-6
(4-(2-Hydroxyethyl)piperazin-1-yl)(phenyl)methanone
AA00DCQ6 | MFCD02973574
524731-02-0
524731-02-0
5-Methylthiophene-3-carbohydrazide
AA00DCTU | MFCD01627991
Submit
© 2017 AA BLOCKS, INC. All rights reserved.